Colorectal, Cancer Clinical Trials in Beijing, Beijing Municipality

19 recruitingBeijing, Beijing Municipality, China

Showing 119 of 19 trials

Recruiting
Phase 1Phase 2

Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

Colorectal, CancerCervical CancerLung Cancer+4 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 1Phase 2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Colorectal, CancerEsophageal CancerOvarian Cancer+12 more
Essen Biotech83 enrolled1 locationNCT07410676
Recruiting
Phase 1

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Colorectal, CancerPancreatic CancerGastric Cancer+1 more
ArriVent BioPharma, Inc.405 enrolled15 locationsNCT07066657
Recruiting
Phase 1Phase 2

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Colorectal, CancerBiliary Tract CancerPancreatic Ductal Adenocarcinoma
Merck Sharp & Dohme LLC220 enrolled55 locationsNCT06428409
Recruiting
Phase 2

A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors

Colorectal, CancerEsophageal CancerGastric Cancer
Sichuan Baili Pharmaceutical Co., Ltd.376 enrolled1 locationNCT06008054
Recruiting

Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients

Colorectal, Cancer
Geneplus-Beijing Co. Ltd.60 enrolled2 locationsNCT06098560
Recruiting
Phase 1

A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors

Breast CancerColorectal, CancerPancreatic Cancer+2 more
Jiangsu Hansoh Pharmaceutical Co., Ltd.318 enrolled1 locationNCT05740956
Recruiting
Not Applicable

Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer

Colorectal, Cancer
Capital Medical University20 enrolled1 locationNCT06584318
Recruiting
Phase 1Phase 2

Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer

Colorectal, Cancer
AbbVie30 enrolled8 locationsNCT06464692
Recruiting
Phase 1Phase 2

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

Colorectal, CancerNon-small Cell Lung CancerKRAS P.G12C+1 more
Allist Pharmaceuticals, Inc.240 enrolled27 locationsNCT05288205
Recruiting
Phase 1Phase 2

Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer

Colorectal, CancerColon CancerRectum Cancer
Essen Biotech85 enrolled1 locationNCT06530303
Recruiting

A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein Blood

Colorectal, Cancer
Peking University Shougang Hospital350 enrolled1 locationNCT06524245
Recruiting

Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan

Colorectal, CancerSolid Tumor
Peking University933 enrolled1 locationNCT06443307
Recruiting

A Prospective Cohort Study on Colorectal Cancer Screening in Community Population

Colorectal, Cancer
Singlera Genomics Inc.18,000 enrolled1 locationNCT05485077
Recruiting

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Not Applicable

Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study

Colorectal, Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences8,000 enrolled1 locationNCT06350370
Recruiting

Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer

Colorectal, CancerLymph Node Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences3,000 enrolled4 locationsNCT06135571
Recruiting
Not Applicable

Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer

Colorectal, CancerNeoadjuvant ChemotherapyImmunotherapy+2 more
Beijing Chao Yang Hospital20 enrolled1 locationNCT05202314
Recruiting
Phase 3

Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

Colorectal, Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University688 enrolled37 locationsNCT04370925